Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial - Wallentin, L; Hijazi, Z; Andersson, U; ARISTOTLE Investigators (Circulation, 2014)